Facile GSH responsive glycyrrhetinic acid conjunction for liver targeting therapy
-
* Corresponding author.
E-mail address: xulu@syphu.edu.cn (L. Xu).
Citation:
Xinran Xi, Xiyu Wang, Ziyue Xi, Chuanyong Fan, Yingying Jiang, Zhenhua Li, Lu Xu. Facile GSH responsive glycyrrhetinic acid conjunction for liver targeting therapy[J]. Chinese Chemical Letters,
;2025, 36(10): 110773.
doi:
10.1016/j.cclet.2024.110773
Y. Zu, L. Meng, X. Zhao, et al., Int. J. Nanomedicine 8 (2013) 1207–1222.
M. Negishi, A. Irie, N. Nagata, et al., Biochim. Biophys. Acta 1066 (1991) 77–82.
doi: 10.1016/0005-2736(91)90253-5
Q. Tian, X. Wang, W. Wang, et al., Int. J. Pharm. 400 (2010) 153–157.
doi: 10.1016/j.ijpharm.2010.08.032
T. Yan, J. Cheng, Z. Liu, et al., Mater. Sci. Eng. C 87 (2018) 32–40.
doi: 10.1016/j.msec.2018.02.013
A. Speciale, C. Muscarà, M.S. Molonia, et al., Molecules 27 (2022) 1775.
doi: 10.3390/molecules27061775
Y. Cai, Y. Xu, H.F. Chan, et al., Mol. Pharm. 13 (2016) 699–709.
doi: 10.1021/acs.molpharmaceut.5b00677
T. Il'Icheva, T. Proniaeva, A. Smetannikov, et al., Vopr. Onkol. 44 (1998) 390–394.
J. Zhang, M. Zhang, J. Ji, et al., Chen. Pharm. Res. 32 (2015) 3376–3390.
doi: 10.1007/s11095-015-1714-2
J. Tian, L. Wang, L. Wang, et al., Drug Deliv. 21 (2014) 553–559.
doi: 10.3109/10717544.2013.853850
G. Martínez-Edo, C. Fornaguera, S. Borrós, et al., Pharmaceutics 12 (2020) 1048.
doi: 10.3390/pharmaceutics12111048
L.A. Stecanella, A.P.R. Bitencourt, G.R. Vaz, et al., Pharmaceutics 13 (2021) 1792.
doi: 10.3390/pharmaceutics13111792
F. Wu, X. Li, B. Jiang, et al., J. Biomed. Nanotechnol. 14 (2018) 1837–1852.
doi: 10.1166/jbn.2018.2638
G. Yan, Q. Chen, L. Xu, et al., Artif. Cells Nanomed. Biotechnol. 44 (2016) 491–496.
doi: 10.3109/21691401.2014.962747
J. Li, H. Xu, X. Ke, et al., J. Drug Target. 20 (2012) 467–473.
doi: 10.3109/1061186X.2012.685475
Z. Li, Y. Chen, Y. Yang, et al., Front. Bioeng. Biotechnol. 7 (2019) 293.
doi: 10.3389/fbioe.2019.00293
P. Yadav, S.V. Ambudkar, N.R. Prasad, J. Nanobiotechnol. 20 (2022) 423.
doi: 10.1007/978-981-16-8395-4_30
S. Dong, Y. Dong, T. Jia, et al., Adv. Mater. 32 (2020) e2002439.
J. Wang, S. Li, T. Luo, et al., Curr. Med. Chem. 19 (2012) 2976–2983.
doi: 10.2174/092986712800672030
C. Yang, D. Li, Q. FengZhao, et al., Org. Biomol. Chem. 11 (2013) 6946–6951.
doi: 10.1039/c3ob40969d
S. Samarajeewa, R. Shrestha, M. Elsabahy, et al., Mol. Pharm. 10 (2013) 1092–1099.
doi: 10.1021/mp3005897
H. Zhou, X. Wang, J. Tang, et al., Polym. Chem. 7 (2016) 2171–2179.
doi: 10.1039/C6PY00045B
X. Meng, Z. Liu, Y. Cao, et al., Adv. Funct. Mater. 27 (2017) 1605592.
doi: 10.1002/adfm.201605592
D. Lapotko, Nanomedcine 4 (2009) 253–256.
doi: 10.2217/nnm.09.2
G. Kong, R.D. Braun, M.W. Dewhirst, Cancer Res. 60 (2000) 4440–4445.
T.S. Hauck, T.L. Jennings, T. Yatsenko, et al., Adv. Mater. 20 (2008) 3832–3838.
doi: 10.1002/adma.200800921
Y.J. Cheng, J.J. Hu, S.Y. Qin, et al., Biomaterials 232 (2020) 119738.
doi: 10.1016/j.biomaterials.2019.119738
J. Gupta, M. Quadros, M. Momin, J. Drug Deliv. Sci. Technol. 81 (2023) 104305.
doi: 10.1016/j.jddst.2023.104305
Y. Yang, F. Tian, D. Nie, et al., Sci. Adv. 6 (2020) eaay9937.
doi: 10.1126/sciadv.aay9937
L. Peng, X. Mei, J. He, et al., Adv. Mater. 30 (2018) 1707389.
doi: 10.1002/adma.201707389
N. Hao, L. Li, Q. Zhang, et al., Microporous Mesoporous Mater. 162 (2012) 14–23.
doi: 10.1016/j.micromeso.2012.05.040
W. Zhang, M. Yu, Z. Xi, et al., ACS Appl. Mater. Interfaces 11 (2019) 46614–46625.
doi: 10.1021/acsami.9b18388
J. Wang, H. Pan, J. Li, et al., Chin. Chem. Lett. 34 (2023) 107828.
doi: 10.1016/j.cclet.2022.107828
J. Ozer, M. Ratner, M. Shaw, et al., Toxicology 245 (2008) 194–205.
doi: 10.1016/j.tox.2007.11.021
N. Tang, Y. Zhang, Z. Liu, et al., Biomed. Rep. 5 (2016) 107–112.
doi: 10.3892/br.2016.681
D. Kukkar, D. Zhang, B.H. Jeon, et al., TrAC Trends Anal. Chem. 150 (2022) 116570.
doi: 10.1016/j.trac.2022.116570
Y. Sun, S. Han, M. Yao, et al., RSC Adv. 10 (2020) 1552–1571.
doi: 10.1039/c9ra08090b
Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
Jiaxu Wang , Jinxie Zhang , Xiuping Wang , Jingying Wang , Lina Chen , Jiahui Cao , Wei Cao , Siyu Liang , Ping Luan , Ke Zheng , Xiao-Kun Ouyang , Li Gao , Xiaowen Ou , Fan Zhang , Meitong Ou , Lin Mei . CaCO3-coated hollow mesoporous silica nanoparticles for pH-responsive fungicides release. Chinese Chemical Letters, 2024, 35(12): 109697-. doi: 10.1016/j.cclet.2024.109697
Zhaomin Tang , Qian He , Jianren Zhou , Shuang Yan , Li Jiang , Yudong Wang , Chenxing Yao , Huangzhao Wei , Keda Yang , Jiajia Wang . Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109742-. doi: 10.1016/j.cclet.2024.109742
Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
Tingting Hu , Chao Shen , Xueyan Wang , Fengbo Wu , Zhiyao He . Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy. Chinese Chemical Letters, 2024, 35(11): 109562-. doi: 10.1016/j.cclet.2024.109562
Lulu Cao , Yikun Li , Dongxiang Zhang , Shuai Yue , Rong Shang , Xin-Dong Jiang , Jianjun Du . Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy. Chinese Chemical Letters, 2024, 35(12): 109735-. doi: 10.1016/j.cclet.2024.109735
Han Han , Bi-Te Chen , Jia-Rong Ding , Jin-Ming Si , Tian-Jiao Zhou , Yi Wang , Lei Xing , Hu-Lin Jiang . A PDGFRβ-targeting nanodrill system for pancreatic fibrosis therapy. Chinese Chemical Letters, 2024, 35(10): 109583-. doi: 10.1016/j.cclet.2024.109583
Mingrui Zhang , Lingyu Jin , Yuda Zhu , Junfeng Kou , Bo Liu , Jing Chen , Xiaolin Zhong , Xianghua Wu , Junfeng Zhang , Wenxiu Ren . A near-infrared Ⅱ fluorescent dye based on oxanthracene: Real-time imaging of drug-induced acute liver injury and photothermal therapy for tumor. Chinese Chemical Letters, 2025, 36(10): 110772-. doi: 10.1016/j.cclet.2024.110772
Jing Guo , Zhi-Guo Lu , Rui-Chen Zhao , Bao-Ku Li , Xin Zhang . Nucleic acid therapy for metabolic-related diseases. Chinese Chemical Letters, 2025, 36(3): 109875-. doi: 10.1016/j.cclet.2024.109875
Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
Xiaosheng Zhao , Jie Gao , Kun Shi , Chixiang Zhang , Wenliang Ma , Guo Lyu , Jun Zhang , Jing Lu , Qiangqiang Liu , Xianjin Luo , Kunru Yu , Jianguo Li , Qiang Ge , Jiming Cai , Chang Liu , Zhiyong Qian . A new radioactive microsphere: Y-90 carbon microsphere for selective internal radiation therapy of advanced liver cancer. Chinese Chemical Letters, 2025, 36(8): 110662-. doi: 10.1016/j.cclet.2024.110662
Du Liu , Yuyan Li , Hankun Zhang , Benhua Wang , Chaoyi Yao , Minhuan Lan , Zhanhong Yang , Xiangzhi Song . Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy. Chinese Chemical Letters, 2025, 36(2): 109910-. doi: 10.1016/j.cclet.2024.109910
Hao Sun , Shengke Li , Qian Liu , Minzan Zuo , Xueqi Tian , Kaiya Wang , Xiao-Yu Hu . Supramolecular prodrug vesicles for selective antimicrobial therapy employing a chemo-photodynamic strategy. Chinese Chemical Letters, 2025, 36(3): 109999-. doi: 10.1016/j.cclet.2024.109999
Lanlan Zong , Yuxin Dai , Jiahao Xu , Chaofeng Qiao , Yao Qi , Chengyuan Ma , Hong Li , Xiaobin Pang , Xiaohui Pu . Luteolin and glycyrrhetinic exert cooperative effect on liver cancer by selfassembling into carrier-free nanostructures. Chinese Chemical Letters, 2025, 36(10): 111325-. doi: 10.1016/j.cclet.2025.111325
Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
Linjie Ju , Zhongxi Huang , Qian Shen , Chan Fu , Shuanghe Li , Wenjie Duan , Chenfeng Xu , Weizhen An , Zhiqiang Zhai , Jifu Wei , Changmin Yu , Guoren Zhou . Glutathione depletion based Pt(Ⅳ) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A “one stone three birds” strategy. Chinese Chemical Letters, 2024, 35(10): 109450-. doi: 10.1016/j.cclet.2023.109450
Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254